Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orphan Vaccine Centers Could Produce Bioterror Products, NRC Report Says

Executive Summary

Government-owned, contractor-operated facilities for orphan vaccines could facilitate mass manufacture of counterterrorism agents, the National Research Council suggested in a June 25 report

You may also be interested in...

Bioterrorism Product Research Tax Credit Expanded Under Lieberman Bill

Bioterrorism product research tax credits would be expanded to include companies with tax liability, such as larger biotech and pharma firms, under reworked legislation being developed by Sen. Joseph Lieberman (D-Conn.)

National Vaccine Facility Would Not Solve Current Shortages, CDC Says

A national vaccine facility would not solve near-term supply problems, Centers for Disease Control & Prevention National Immunization Program Director Walter Orenstein, MD, suggested

BIO Vaccine Indemnification Proposal Would Require Govt. To Defend Suits

The Biotechnology Industry Organization's indemnification proposal would require the government to defend against claims arising from potential adverse effects of bioterrorism vaccines

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts